FindTrial
Sign In

Iopofosine I 131

DRUG2 trials

Sponsors

Cellectar Biosciences, Inc.

Conditions

Breast CancerWaldenstrom MacroglobulinaemiaWaldenstrom MacroglobulinemiaWaldenstrom Macroglobulinemia With Nodal DiseaseWaldenstrom's Macroglobulinaemia RefractoryWaldenstrom's Macroglobulinemia Recurrent

Phase 1

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
RecruitingNCT07311993
Cellectar Biosciences, Inc.Breast Cancer
Start: 2025-12-05End: 2029-07-01Target: 60Updated: 2026-06-03

Phase 3

Evaluation of Iopofosine I 131 vs. R-CD in WM Patients
Not yet recruitingNCT07766421
Cellectar Biosciences, Inc.Waldenstrom Macroglobulinaemia, Waldenstrom Macroglobulinemia, Waldenstrom Macroglobulinemia With Nodal Disease +2
Start: 2026-12-01End: 2035-01-01Target: 219Updated: 2026-08-14